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AUSTHACT. Chronic inflammation is a process where dendritic cells (DCs) are 
constanUy sampling anUgen in the skin and migraUng 1,0 lymph nodes where 
they induce the adivaUon and prolHeraUon 01" T cells. The T cells then travel 
back to the skin where they release cytokines that induce/maintain the inflam-
matory condition. This process is cyclic and ongoing. We created a differential 
equations model to reflect the initial stages of the inflammatory process. In 
part,icular, we modeled anUgen sUmulaUon 01" DCs in the skin, movement 01" 
DCs 1"rom the skin 1,0 a lymph node, and the subsequent adivaUon 01" T cells in 
the lymph node. The model was able 1,0 simulate DC and T cell responses 1,0 
anUgen introdudion taking place within realistic Ume scales. The goal 01" such 
a preliminary model is simply 1,0 be able 1,0 capture biologically realistic dy-
namics. Future models can then build on this preliminary model in diredions 
that can potenUally allow not only 1"or model validaUon, but 1"or predicUons 
and hypothesis tesUng. 
1. Background. 
1.1. The motivation. The primary function of the irnrnune system is to protect 
the body from foreign, potentially pathogenic, invaders. The symptorns of the 
earliest stage of a normal immune response, inflammation, are redness, swelling, 
pain and increased local temperature. The initiation of inflammation by skin in-
fections or damage to the skin triggers resident skin cells to release molecules that 
cause blood vessels near the skin surface to become permeable. This increase in 
blood vessel permeability allcHvfi irnrnune cells and factors circulating in the blood 
to rapidly enter the infected or damaged area and, as a consequence, initiate the 
development of immunity. When infection or damage occurs for the first time, pre-
cursors of cells that initiate irnrnunity are recruited out of the blood follm'ling a 
gradient of molecules called inflammatory chemokines that are induced at the site. 
In order to follow chemokine gradients produced during inflammation, these cells 
require receptors on their surface for specific types of inflammatory chemokines. 
The material, generally derived from microbes, that the irnrnune cells react to at 
the site of inflammation is known as antigen. A subpopulation of immigrant cells 
rapidly develops into dendritic cells (DCs) in the skin that sample and process the 
antigen for presentation to T cells ''lithin local lymph nodes. Coincident ''lith anti-
gen uptalce, DCs are activated by a '"danger sigl1aF' that induces maturation of 
the cell resulting in receptor type changes displayed on the cell's surface (Figllre 
1). 1-licrobial DNA, RNA from viruses, bacterial peptidoglycan aJld lipopolysaccha-
ride (LPS) caJl all act as danger signals. Cytokines, soluble intercellular messenger 
molecules produced during inflammation, e.g., tumor necrosis factor alpha (TNF-
Q), also act a."i intrinsic danger signals for DCs, for example in the chronic disease 
model such as psoria."iis [1, 101. The ne,'l receptors resulting from the danger signal, 
referred to as CCR 7 receptors, enable DCs to follm'l a gradient of another set of 
chernokines, the constitutive chemokines, termed CCL19 and CCL21, ''lhich guide 
the cells from the skin via lymphatic ducts to the lymph node. \~.Tithin specialized 
areas of the lymph node, antigen is presented by DCs to T lymphocytes. These T 
lymphocytes are constaJltly circulating from the blood system through the lymph 
nodes. Those T cells that recognize antigen presented by DCs become activated 
and proliferate ''lithin the lymph nodes. Eventually, the T cells leave and travel to 
the skin to assist in the removal of the antigen by secreting molecules that drive 
inflammation. A gradient of chemokines is again required for this movement. Dur-
ing a normal response, inflammation ceases once the antigen is removed or healing 
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epidermis 
FIGUHB 1. Chronic inflammation: A process where dendritic cells 
are constantly being recruited to the skin from the blood (1) saJn-
pling antigen in the skin and migrating to the lymph node (2) ,vhere 
they induce the activation and proliferation of T cells (3) that travel 
bade to the skin ,vhere they release cytokines thus maintaining the 
inflammatory condition. 
is complete. Smne components of this irnrnnne cell movement are not restricted 
to the inflammatory response. In non-inflamed healthy skin, minor traffic of DCs 
from the skin to the lymph nodes consistently occurs. The purpose of this "steady 
staten migration is to a.%ist the irnrnune system in remaining toleraJlt tmva.rds body 
components, i.e., "selC' 
On occasion, the immune system induces prolonged skin inflammation. This 
chronic inflammation is due to an aberrant immune response to either foreign ma-
terial or to normal body components that does not resolve. In this situation, cells 
continue to produce cytokines and chemokines and to move in and out of the skin 
which prolongs inflammation. One way to intervene in this process is to block 
the movernent of irnrnune cells. 1.folecules derived from viruses, termed chernokine 
binding proteins, have been identified that have the capacity to do this and there-
fore may have potential as anti-inflammatory therapeutics. We are interested in 
developing a mathematical model of this. Preliminary to this, ,ve need to model 
(1) the recruitment of blood derived DCs in response to inflammatory stimuli and 
antigen in the skin, (2) the trafficking of antigen-loaded skin DCs to the node, and 
(3) subsequent T cell activation aJld proliferation under normal conditions. The 
mathematical model described in this paper represents these events. 
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2. The model. An ordinary differential equation (ODE) model was developed that 
enabled us to measure the levels of DCs in the lymph node, DL (DCs/mg of lymph 
node), and in the skin, Ds (DCs/mg of skin), over time t (in hours). In addition, 
the aJltigen concentration, A. (ng of antigen/mg of tissue) and the number of effector 
T cells (both CD/l aJld CD8), denoted T (''lith units of cells/mg of nodal tissue) 
\vere tracked. All model parameters and initial values are given in Table 1. 
Regarding ''lhat "antigenll represents in the context of our model, ''le note that 
antigen that provokes DC movement in the first instance may be microbial, in 
which case it will replicate, and at a specific threshold (generally poorly defined), 
sufficiently activated DC will exit the skin. Alternatively, antigen may be a finite 
amount of protein which by definition will not increase. An example may be a 
contact allergen applied to the skin. And yet again, microbial antigen may mimic 
"self aJltigenll so that in aJl autoirnrnune disease, the irnrnune response, initiated by 
antigen from the environment, may be perpetuated by a constaJlt supply of "seIF 
antigen, for exmnple, cell components. Since our model is limited to incorporat-
ing the initiation of DC activation and movement to the draining lymph node in 
response to a given antigen, we have chosen to use a defined, finite quantity of 
proteinaceous antigen in this preliminary model. Since different microbes replicate 
at different rates under different conditions, it would be difficult to do otherwise. 
We note that in a case of chronic inflammation, the model would be far more 
complicated, and more than one lymph node ''lould be involved. IIm'lever, in this 
preliminary model of DC trafficking, we focused on modeling the dynamics within 
only one lymph node. This model describes mathematically the induction of T 
cell immunity in the skin, as a first step toward developing a model of chronic 
inflammation. We incorporated only the simple elements of DC antigen acquisition, 
activation, movement, and T cell stimulation. Future, more complex, models can 
build on this preliminary model in directions that can potentially allm'l not only for 
model validation, but also for predictions aJld hypothesis testing. 
2.1. Assumptions and ODEs. The mathematical model uses the follm'ling as-
surnptions: 
1. The concentration of DCs in the blood, DB, remains relatively constant 
throughout the simulation. This implies that an ODE representing DCs in 
the bl~)()(l \vould have the form d~tD ;::::; 0 for the duration of the infe(:tion and 
subsequent inflammation, and thus an equation for DB is not included. 
2. Antigen accumulates in the skin linearly over time until it reaches a maximurn 
level There is no evidence that this is not the c~J.."ie, and it allcnvfi for a tractable 
mathernatical implementation. 
3. In the absence of sufficient antigen, the number of DCs that migrate to the 
lymph nodes is very smalL Sufficiently high levels of antigen stimulate in-
creased DC flow from the blood to the skin and thus from the skin to the 
lymph node. 
11. Dendritic cells do not proliferate in the skin. This assumption is based on data 
derived from the inflammatory response when immigrant monocytes enter the 
skin, differentiate, acquire antigen in the presence of co-stimulatory danger 
SiglUllS and migrate to the draining nodes. Langerhans Cells, the normal 
residents, are knm'ln to turn over (that is, replicate) extremely slm'lly in the 
skin [6, 11]. Dendritic cells that are known to participate in an inflammatory 
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response are recruited primarily as monocytes from the blood and are not 
knm'ln to proliferate in the skin. 
5. \~.Te knm'l that behveen Cl.Ol % and 3% of mature antigen-loaded Des that 
leave the skin get to the node [8]. This suggests that there are probably quite 
large losses along the ''lay possibly during migration. In the model, ''le are 
only interested in tracking those Des that pick up antigen in the skin and are 
capable of activating T cells once they reach the lymph node. Therefore, ''le 
''lill assume that Des that reach the node are all capable of activating T cells. 
6. T cells do not begin to proliferate until the concentration of Des in the lymph 
node reaches a certain threshold. This critical threshold is represented in the 
model by parameter DL"rir' 
The cycle of De activation begins ''lith aJltigen stimulation. A fe,'l hours after 
initial antigen stimulation, antigen is assumed to reach a sufficiently high level to 
elicit an inflammatory response. In particular, we represent the process of infection 
initiation by allm'ling antigen concentration, A, to increase linearly ''lith time from 
the start of the simulation until A reaches a maximum threshold, Athrei-ih (see As-
surnption (2)). The time at ''lhich this threshold is reached is tthrei-ih' For simplicity, 
\ve assume that antigen levels A increase by one ng per mg of tissue per hour, un-
til reaching threshold Athrei-ih. Defore that threshold is reached, a lm'l level of Des 
continuously flows from the blood into the skin. This constant inflow is represented 
by aDD (see equation (2) belm'l). Once aJltigen levels in the skin hit the critical 
threshold, Athrei-ih, Des are recruited from the blood into the skin at a higher rate. 
In the model, this is represented by having the value of aDD increase (see discussion 
in section 2.3). \~.Te make the assumption that the increase in the recruitment rate 
takes place on a short enough time scale that the increase in aDD can be approxi-
mated by a discrete jump from a non- inflamed value to an inflamed value, and that 
the use of a continuous function to represent this grm'lth is not currently required. 
A continuously increasing recruitment parmneter can be incorporated in a future 
model. 
Dendritic cells in the skin, Ds , continuously flow out and travel to the lymph 
node. The rate of transfer from the skin to the lymph node is described by a rate 
function I( = I( (D s, D L ). As the nurnber of Des in the skin increases, the rate at 
\vhich Des migrate from the skin into the lymph node is moderated by the function 
IC The form of I( is outlined in detail in section 2.2. 
As noted in Assumption (/1), there is no De proliferation in the skin. This, along 
\vith the aforementioned antigen activation cycle, suggests that the rate of chaJlge 
of the Des in the skin caJl be described by the equation 
dDs T & = aDD - B .. (Ds,DL)Ds. 
The Des that arrive in the lymph node are assumed to corne solely from the 
population of Des in the skin. In this model, Des leave the skin at a rate described 
by the rate function I( and arrive in the lymph node at that same rate. The Des 
in the lymph node diminish only through death at a rate b (per hour). IIence, 
the differential equation describing the rate of change of the DC population in the 
lymph node is 
dDL T 
-it = B .. (Ds,DL)Ds - bDL. 
(,. 
Finally, the T cell population is assumed to grm'l logistically ''lith grm'lth rate 
a (D L , t) (per mg per hour) to a carrying capacity n I. times the size of the maximurn 
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nurnber of Des in the lymph node (,ve denote maximurn nurnber of Des in lymph 
node by DLmaJ. This pan1meter m. has a ,vide range, and ,ve chose the value 
m. = 10 ,vhich means that at carrying capacity, each De presents antigen to 10 T 
cells in the lymph node. Note that the grmvth rate, a(DL' f), is not constant but 
a function of the concentration of Des in the lymph node a."i ,veIl as of time. By 
Assumption (6), T cells ,vill not be stimulated until the concentration of Des in 
the lymph node reaches a critical threshold, represented in the model by DLcrir' 
The time at ,vhich DLcrir is reached is stored as ferit and a(DL' f) increases 
linearly over time to its maximurn value a ula.x . The equation describing the rate of 
change of the T cells is given by 
dT 1/'( D T) 
- = a.L til. L -'. df max 
\vhere a is a function of D L and time and is defined as 
{ 
0 
a DLJ = . a. t-t.· ( .) rrlln( m«x( enr) a ) 
t"" '[lIe\.X 
if DL < DLcrir 
if DL ~ DLcrir. (1) 
\~.Te chose a to have this time-dependent form for the follmving re·a."ions. The T-cell 
population should not be stimulated to grmv at all until the critical De threshold is 
reached. At that time, the intention is not simply to discretely s,vitch on the T-cell 
stimulation by Des, but to allmv T-cell stimulation by Des to increa."ie linearly 
\vith time until stimulation levels are at a maximurn. This is achieved through the 
time-dependent form of a. \~.Te set fa = 72 hours, ,vhich is an arbitrary choice that 
allmvs the a function three days to achieve its maximum value. 
In sUlnrnary, the model equations are given by: 
dD s (A. A. ) T ( ) 
-if = aDD -" ,-" threi-ih - I\. D s , DL Ds 
c. 
(2) 
(3) 
dT 1/'( D T) 
- = a.L 'fI1. L -'. df max 
2.2. The rate function IC To determine the rate function I(, we first considered 
o < f < fthrei-ih. At this time, ,ve let I( = I(o since there ,vill only be minimal 
nurnbers of antigen loaded Des migTating to the lymph node before antigen levels 
reach their critical activation threshold. For f > fthrei-ih, ,ve used results from [8] and 
estimated that the nurnber of Des in the skin doubles as the rate approximately 
triples. Therefore, I( = I(o (31og2(D<s'/D~,)) , \vhere I(o is the initial rate at ,vhich 
activated Des move from the skin into the lymph node. The value of D'S represents 
the number of Des that have entered the skin by time fthrei-ih. D'S changes in 
magnitude ''lith aD D to be consistent ''lith experimental data. From the experiments 
of [7], the rate at which Des enter uninflamed skin is 2 Des per mg of skin per 
hour (see discussion of aDD in section 2.3). By the same experiment, the rate 
of Des entering 1 mg of inflamed skin per hour is 100. Therefore, we will allow 
D'S to be the nurnber of Des in the skin at time fthrei-ih· Thus, D'S = fthrei-ih aD D , 
for the uninflamed value of aDD" This equation holds as long as there is sufficient 
space in the lymph node for ne,v Des to enter, that is, DL < DL,uax' Once the 
threshold ha."i been reached, I((Ds,DL ) measures the rate at ,vhich Des from the 
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qualltity 
D3 
T 
A. 
tthr,,~h 
D~, 
8 
a(DL,t) 
'(fl-
Qnla.x 
K 
TABLE I, Table of model variables aJld parameters. 
UlIih.; Illitial Value 
Variable:.; 
de!l(lritic celli-i / lIIg :.;kill o 
de!l(lritic celli-i / lIIg IYlllph lIode o 
Prillled T celli-i / lIIg IYlllph lIode 
Panulleter:.; 
lIg of alltigell/lIIg of ti:.;:.;ue o 
hr 4 
lIg of alltigell/lIIg ti:.;:.;ue 4 
de!l(lritic celli-i/lIIg IYlllph lIode 
de!l(lritic celli-i/lIIg IYlllph lIode 
de!l(lritic celli-i/lIIg of :.;kill/hr 
de!l(lritic celli-i / lIIg :.;kill tthr,,~haD D 
l/hr 1/72 
l/(hr T cell:';/lIIg IYlllph lIode) 0 
T celli-i/delldritic cell 10 
l/(hr T cell:';/lIIg IYlllph lIode) 0.1 
l/hr 2.0R X 10- 7 
{ A.thr"~h 
(Jhallge 
dD L 
-----;rr-
if A. < A. thr,,~h 
othenvi:.;e 
NOlie 
NOlie 
NOlie 
NOlie 
NOlie 
NOlie 
Lillear fUllctioll, :.;ee eq. (1) 
NOlie 
NOlie 
See equatioll (5) 
skin caJl replenish those Des that died in the lymph node. If DL ~ D Lmax ' then 
the maximum rate I( is given by I( = (bD L) / Ds. This maintains the steady state 
population of DL = DLmax' 
Therefore, ,ve have 
if f > fthre:.;h 
and DL < DLmax (5) 
if f > fthre:.;h 
and DL ~ DL,uax 
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The rate function I( uses the nurnber of Des in the skin as a proxy for the 
physiological roles of tumor necrosis factor (TNF), the chemokine gradient and 
other biological elements that influence DC migration. 
2.3. Parameters and initial conditions. To allm'l for a nurnerical examination 
of the model system, ''le had to choose parameter values. In this section, \ve describe 
hm'l ''le arrived at particular parameter values and initial conditions. 
• Ds (0) = 0: Ds (0) is the nurnber of Des in the skin at time zero, and is zero 
initially, since ''le don't expect there be any activated Des in the skin prior 
to the introduction of antigen. 
• DL (0) = 0 : DL (0) is the nurnber of Des in the lymph node at time zero, 
and is zero initially, since ''le don't expect there be any activated Des in the 
lymph node prior to the introduction of antigen. 
• T(O) = 1: There can be on the order of 10 fl T cells per lymph node, but before 
antigen stimulation, there should be no primed T cells. For the purposes of 
streamlining the mathematical model, ''le chose to represent T cell dynamics 
by a logistic grm'lth term, ''lhich requires mathematically a non-zero initial 
condition in order to allm'l for any population grm'lth. Therefore, ''le allm'led 
for a negligible nurnber of sensitized T cells per mg of lymph tissue ''lhen ''le 
initiated the simulation (one per mg of lymph tissue). 
• "fII. = 10: \~.Te estimate that there are approximately 10 T cells per De in the 
lymph node, and therefore, the carrying capacity of T is "fIlDLmax 1:3]. 
• fthrei-ih = 11: The time at ''lhich antigen levels A reach Athrei-ih' See further 
explanation belm'l for Athrei-ih. 
• Athrei-ih = 11: In our model, ''le allm'l antigen levels to incre~J.."ie at a rate of 1 
ng/mg of tissue per hour. This is a guess, and ''lill vary depending on the 
organism. For this reason, ''le allm'l Athrei-ih = fthrei-ih times 1 ng per mg of 
tissue per hour. In our case, ''le estimated Athrei-ih to be 11 ng/mg of tissue, 
the point at ''lhich Des start getting recruited from the blood to the skin, 
after ''lhich the Des talce up the antigen, and migrate to the lymph node. 
The process of T cell activation by Des in the lymph node is initiated once 
the concentration of Des in the lymph node reaches DLcrir cells/mg of lymph 
node. Since there is evidence that De activation takes place about 2 to 11 
hours after initial antigen stimulation [5], ''le set fthrei-ih at 11 IB]. 
We note that inflammation is initiated by a danger signal, and this danger 
sigl1al comes from the same mic[(}-organism ~J.."i the antigen, as discussed in the 
introduction of this paper. Such danger signals are not explicitly accounted 
for in our model, but instead ''le allm'l the threshold antigen level to dictate 
the initiation of the inflammation response. We assume that there is sufficient 
accompanying danger signal to initiate the inflammatory response, allowing 
De recruitment from the blood to the skin. 
• DLcrir = 3 X l(P: According to [3, 9] 3000 antigen-presenting cells per lymph 
node, or 300 cells/mg lymph node (assuming a 10 mg lymph node), is adequate 
for T cell response. In our model, we record the first time DLcrir is reached 
as f erit . Thereafter, the T-cell growth coefficient a(DL' f) grm'ls linearly ''lith 
time until its value reaches the maximurn, alllCl.X' 
• DLmax = 2 X 104 : The lymph node in a mouse can hold about 2 x 105 Des [8], 
''lhich is 2 x 104 cells/mg of lymph node ''lith the assumption that the lymph 
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node is approximately 10 mg. \~.Te let DLmax denote the maximum number of 
DCs per mg of lymph node . 
• 2 ~ aDD ~ 125 (uninflamed), 100 ~ aDD ~ 6250 (inflamed range): 
This is the rate of the DCs entering 1 mg of skin from the blood per hour. 
Rate values for aDD are pre and post-threshold levels of antigen. The lmver 
bound for the pre- threshold levels m"e based on the experiments of [7], and 
the upper bound pre-threshold value is chosen to be a percent of the upper 
bound post-threshold rate of DC entering inflamed skin. When aDD repre-
sents the rate of blood-derived DCs that are recruited to uninflamed skin per 
hour, the lmver bound value is aDD = 2± (1 SD) / mg of skin per hour. This 
value of aDD ,vas obtained from experiments in ,vhich DC recruitment from 
the blood was performed using egfp DC (DC expressing green fluorescent pro-
tein) adoptively transferred into syngeneic recipients. Done maumv DCs ,vere 
cultured from C57DI/6 mice as previously described [2]. 3 x 1()'i egfp DCs 
,vere administered into sex matched C57DI/6 recipients via the tail vein 1:1]. 
Forty hours later mice were sacrificed and an area of skin from the abdomen 
,vas excised, 'veighed and the irnrnune cells isolated by enzymatic digestion. 
The egfp DCs ,vere enumerated by staining the cells ''lith a monoclonal anti-
body to the cell surface glycoprotein CD11C. The data ,vere obtained using 3 
mice per experimental group and 2 experiments ,vere performed. 89 DC ±5/1 
(1 SD)/mg of tissue were found to be recruited to un inflamed skin over a 48 
hour period. The experiment described here and experiments described belmv 
for determining aD D in the inflamed state were approved by the Animal Ethics 
Committee, University of Otago. The upper bound value for the un inflamed 
rate aDD is chosen to be 2% of the upper bound value of the inflamed aDD' 
since the lower bound uninflamed value is 2% of the lower bound inflamed 
value. Since the upper bound on the inflamed value is 6250 (see discussion 
below), we have the upper bound on the uninflamed set at 125" 
The range of values for the inflamed state were determined as follows: they 
are based pmtially on the experiments carried out in [71, and partially on the 
data provided in [8]. In the experiments of [7], 1()'i ,vhite blood cells ,vere 
inj ected into the blood (through the tail vein) of three DLD /6 mice in hvo 
experiments (for a total of six mice). The injected cells ,vere mm"ked ''lith 
CD11c for the tracking of the nurnber of DCs. After 2/1 hours, a mean of 
2/100 (±9/1) DCs per mg of skin ,vere hanrested from the mice. So in this 
experiment, about 100 DCs per mg of skin appear to enter the skin per hour. 
\~.Te ,vill allmv this to determine the lmver end value of aDD' setting it to 100. 
According to [31, about 300 DC/mg of lymph node are needed to initiate aT 
cell response. The experiments of [7] are consistent ''lith this. 
In order to get an upper bound on aDD' ,ve look at [8], in ,vhich ,ve see that 
in smne c~J.."ies, as fe,v as about 0.1% of activated DCs in the skin manage to 
migrate to the lymph node. If ,ve ,vork badnvards from the threshold of 300 
DCs/mg of lymph node needed to activated a T cell response, assume that 
it takes about 2 days, or 118 hours, for the activated DCs to build up to that 
level in the lymph node, and then suppose that only 0.1 % of activated DCs 
actually make it to the lymph node (according to [81), ,ve have the follmving 
outcome: 300 DC/mg of lymph node built up over 118 hours means an average 
of 6.25 DCs/mg of lymph node are entering the lymph node per hour. If this 
represents only 0.1 % of the activated DCs that make it from the skin to the 
.! 
Gi (J 
'0 
I: 
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lymph node, then there must be about 6250 activated DCs/mg of skin per 
hour. \~.Te choose this to be our upper bound on aDD' 
• D'S = fthrei-ihaDD : This represents the number of activated DCs that have 
arrived in the skin at the time fthrei-ih ,vhen antigen levels have reached their 
critical threshold. 
• is = 1/72: Dendritic cells die in the lymph node after approximately 3 days, 
so the rate of DL dying in the lymph node per hour, is, is 1/72. The estimates 
of a three day life span are given in [6]. 
• alllCl.X = 0.1, 0 ~ a(DL,f) ~ alllc\'x: This is the grmvth rate ofT cells in 1 mg 
of lymph node per hour. \~.Te chose alllc\.X = 0.1, ,vhich is a guess, and a value 
that allmvs the T cell population to increase at a biologically reasonable rate. 
See equation (1) for further discussion of a (D L , f). 
• I(o = 2'()8 X 10-7 /hour: The initial rate at ,vhich mature DCs are recruited 
from the skin into the lymph node prior to antigen levels reaching their critical 
threshold Athrei-ih. The value for I(o ,vas estimated by taking values from an 
experiment in [8]. In this experiment, ,vhen 105 DCs ,vere injected into the 
skin, the rate of migTation ,vas O.OOCll after 2 days, ,vhich is equivalent to 
2'()8 x 10- fl per hOI1r. Since ,ve expect the rate of migration to be lmver before 
critical antigen levels aJ'e reached, ,ve ,vill assume that the rate I(o is an order 
of magnitude less than this measured rate, and therefore ,ve let the value of I(o 
be 2'()8 x 10-7 /hour. Plots of vaJ'ious rate functions I( are shmvn in Figures 
2 through 5. 
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FIGUHB 2. Numerical simulation of cell concentrations, ''lith cor-
responding I( rate function. Initial pan1meters and variables in 
Table 1. aDD = 100. 
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3. Numerical experiments. In this section, ,ve present simulation outcomes us-
ing a range of parameter values. We investigated the effect of the parameter aDD 
on the outcome of the model in an inflamed state. As noted, we assumed that in 
the inflamed state, aDD may range from around 100 up to approximately 6250. 
As can be seen in Figures 2 through 5, a change in aD D affected not only the cell 
concentrations over time but also the rate function Ie \~.Then antigen levels are 
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Table 1. aDD = 1000. 
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Im'l, aDD is set to be behveen 2 and 125 cells per mg per hour (that is, 2% of 
the inflamed aDD value). When the antigen level is beyond a fixed threshold, the 
higher inflamed value of aDD kicks in. Note that for all values of aDD' ''le observe 
cell-concentration dynmnics that appear to be biologically realistic. N mnely, 
• T cells do not respond until about 2 days after infection. It takes around one 
day for cells to migrate from the skin to the lymph node [8], and thereafter 
around 20 hours for the T cell response to kick in [/1]. Thus the 2 day lag time 
seems to be a reasonably realistic time scale . 
• Dendritic cells in the skin aJld lymph node begin to grm'l quickly. 
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responding I( rate function. Initial pan1meters and variables in 
Table 1. aDD = 6250. 
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• DL < Ds since Des in the lymph node cmne from Des in the skin. This 
difference becomes more pronounced for higher values of aD D' 
• T cells reach a maximurn equilibrium value. 
• Once DL reaches its maximurn value, Ds begins to grmv since Des in the skin 
migrate at a lmver rate from the skin to the lymph node. 
• DL achieves its steady state value roughly at the same time T cells do. This 
is appropriate since DLs stimulate T cell production. 
In the inflamed state, when aDD increases to 500 and higher, ,ve notice that the 
T cell response takes place more quickly (see Figures 2 through 5). As expected, 
the concentrations of Des in the skin and in the lymph node increase more rapidly 
in the initial hours. For aDD at 100, steady state values are achieved for Des in the 
skin and lymph node, and are about equal. For the larger values of aDD' the Des 
in the skin appear still to be increasing, even at time 250, but the Des in the lymph 
node have achieved their steady state value of around 104 Des per mg of lymph 
node (the rnaximurn that can be held in the lymph node tissue). For aDD = 100, 
the steady state value for the Des in the lymph node is achieved around hour 250, 
but for the larger value of aDD = 6250, the steady state value is achieved as early 
as honr 50. 
Notice, also, that the rate function I( is affected by the change in the value of 
aDD' becoming increa . ;;ingly naumv, as ,veIl as decrea . ;;ing in maximum height, as 
aDD increases. See Figures 2 through 5. A nice feature of the I( function is that 
at its maximurn, it never exceeds 1.2%, ,vhich is consistent ''lith the measurements 
in [8]. 
/1. Discussion. The model presented here is an initial step tmvard solving the 
problem of chronic inflammation. The model reflects the basic biology behind the 
irnrnune response to antigen, and the simulations shmv biologically reasonable re-
sults. IImvever, smne additional steps need to be taken in order for this model to be 
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usable as a foundation for realistically addressing hmv a chemokine-binding protein 
can inhibit DC movement. 
The next steps in developing this model ,vill include: 
• Cell loss 'in tTan,4rit'ion. Currently, ,ve assume that DCs leave the skin and 
arrive in the lymph node at a rate IC It may be useful to explore the effect of 
concurrent cell loss. In the model, this is easy to implement. \~.Te can introduce 
a parmneter p, ,vhere 0 ~ p ~ 1, and simply modify the equation for the DCs 
in the lymph node to read a."i follmvs: d~/ = pK(Ds,DL)Ds - bDL. 
• The Tate jlLnd'ion Ie I((Ds , D L ) is a simplified function in which the physi-
ological roles of tumor necrosis factor (TNF) and the chernokine gradient are 
not included explicitly, but their roles in DC migration are only approximated 
by the nurnber of DCs in the skin. Future models ,vill incorporate secondary 
chemokines such as CCL19 and CCL21 as well as the TNF's effect on in-
flammation and secondary chemokine production. In addition, we hope to 
find better values for parameters, potentially through designing experiments 
in collaboration behveen the mathernaticians and the biologists. Since move-
ment of DCs from the skin to the lymph node is not an instantaneous process 
biologically, ,ve plan to investigate the introduction of a time delay behveen 
DC loss from skin and arri val at the lymph node. \~.Te note here that ,ve model 
the lymph node, and not the lymph, because ,ve caJl obtain data from the lit-
erature aJld from our mvn experiments. Deriving data from lymph is not easy 
in the mouse. It can be done in larger experimental aJlimals by cannulating 
lymphatic vessels, for example in the rat [12]. 
• Capturing chronic infiammation. In this preliminary model, ,ve have not yet 
included T-cell clearing of antigen, and the persistence of the T-cell population 
once it is activated is essentially imposed. In a future model that ,vill build 
on this model, and in ,vhich ,ve intend to capture the mechanisms that lead 
to chronic inflammation, the dynamics will have to be modified to allow the 
inflamed state to emerge from a set of rules that do not explicitly impose such 
a state. 
• The 'value of aDD' aDD is the rate at ,vhich DCs are recruited into skin, ,vhich 
depends on the antigen concentration. \~.Then the antigen concentration has 
not yet reached a threshold, Athrei-ih, we consider that inflammation has not 
been triggered. \~.Te are currently investigating an implernentation of a more 
biologically accurate definition of aDD' 
Acknowledgments. \~.Te ,vould like to thank the organizers of the December 2007 
\vorkshop, "The Application of 1.fathernatics to Biomedical Problems/' including: 
Prof. Ami Radunslcaya of Pennema College, Dr. Sarah IIook of the University of 
Otago, aJld Prof. Urszula Ledze,,,icz of Southern Illinois University. In addition, we 
thank the School of Pharmacy, University of Otago, Dunedin, NZ, for hosting the 
workshop and gratefully acknowledge the financial support of the NSF, Grant No. 
0737537. Finally, we thaJlk the reviewers for their time and invaluable suggestions. 
REFERENCES 
[1] S. Benko, Z. Magyarics, A. Szabo and E. Rajnavolgyi, Dendnlu: cell :mblJJpes as pnmaTJJ 
ll1.1~qels of vaccmes: lhe eme1~qm.q TOle and cTOss-lalk of palleTn Teco.qn2lwn TeceploTS, Biol. 
Chem., 389 (200,s), /1f)9 /1,sf). 
AI.vlY H. LIN ERICKSON ET AL. 
[2] L. Faulkner, G. S. Buchan and Tv!. A. Baird, Interleukin-l0 does not affect phagocytosis of 
po.Tlu:ulo.le o.nlt.qen by bone ml1.1T01J.l denved dendnlu: ce1l8 Iml doe8 tmpatT o.nlt.qen 7We8enlo.-
lwn, Immunolog.v 99 (2000), G2:{ G:U. Dendnltc cell :mb8el8 m hp .. allh o.nd dt8e0.8e, Immunol. 
Rev., 219 (2007), 1LS-H2. 
[:{] Tv!. Hommel and B. K.vewski, Dyno.mtc cho.n.qe8 dunn.q lhe tmmune 1'f'.8pOn8e m T cell-o.nlt.qen-
7we8enlm.q cell clu8leT8 t8010.led .fmm lymph node8, .T. Exp. TvIed., 197 (20m), 2fl9 2kO. 
[:1] G. Iezzi, K. Karjalainen and A. Lanzavecchia, The dUTO.lwn of o.nlt.qemc 8ltmulo.lwn deleT-
mines the fate of naive and effector t cells, Immunit,.v, 8 (l99k), k9 9G. 
[G] T. B. Issekut,z, A. C. Issekut,z and H. Z. TvIovat" The m 1.'21.'0 IJ1w.nltlo.lwn o.nd kmeltC8 of 
monocyte migmtion into acute inflammatory tissue, Am . .T. Pat,hol., 103 (20m), :17 GG. 
[fl] A. T. Kamat,h, S. Henri, F. BaU,.ve, D. F. Tough and K. ShOltman, Developmenll1.l kmeltC8 
o.nd hfe8po.n of dendnltc ce1l8 m mOU8e lymphoui 01~qo.n8, Blood, 100 (2002), 17:H 1 HI. 
[7] Z. Lat,eei", Tv!. Baird and S. Fleming, Cnpublished dat,a. 
[k] A. TvIarUn-Font,echa, S. SebasUani, C. E. Hopken, Tv!. Cguccioni, Tv!. Lipp, A. Lanzavecchia 
and F. Sallust,o, Re.qulo.lwn of dendnltc cell mt.qTO.lwn lo lhe dTO.mm.q lymph node: Impo.cl 
on T lymphocyte tmffic and priming, .T. Exp. TvIed., 198 (20m), fllG fl2I. 
[9] C. C. Korbur.v, D. TvIalide, .T. S. Gibbs, .T. R. Bennink and .T. \V. Yewdell, \/t8uo.hzm.q pnmm.q 
of virus-specific CD8+ T cells by infected dendritic cells in vivo, Kat,. Immuno, 3 (2002), 
2flG 27l. 
[10] H. Ceno, E. Klechevsk.v, R. TvIorit,a, C. Aspord, T. CaD, T. TvIat,sui, T. Di Pucchio, .T. Connoll.v, 
.T. \V. Fa.v, V. Pascual, A. K. Paluck,~ and .T. Banchereau, Dendnltc cell :mb8el8 2n hel1.llh o.nd 
dt8e0.8e, Immunol. Rev., 219 (2007), 11k H2. 
[11] Tv!. Vishwanat,h, A. Kishibu, S. Saeland, B. R.. \Van}, K. TvIizumot,o, H. L. Ploegh, Tv!. Boes and 
A. Tak,~shima, Developmenl of mlm1.'2ll1.l tnleTmtllenl confor .. al tmo..qm.q 8Y8lem .fOT 8ludytn.q 
10.n.qeTho.n8 cell lUTnoveT, .T. Invest,. Dermat,ol., 126 (200fl), 2:1G2 2:1G7. 
[12] C. Yrlid, V. Cerovic, S. TvIilling, C. D . .Tenkins, .T. Zhang, P. R.. Crocker, L. S. Klavinskis 
and G. G. TvIacPherson, Pl0.8mo.cyloui dendnltc ce1l8 do nol m2qTO.le m tnle8ltnl1.l 01' hepo.ltc 
lymph, .T. Immunol., 177 (200fl), flllG fll2I. 
Received September 2008; revised April 2009. 
E-mo.tl o.ddTe88: aeri ekso@gge . usg. edu 
E-mo.tl o.ddTe88: awise@bios. une . edu 
E-mo.tl o.ddTe88: stephen. fleming@stonebow. otago. ae. nz 
E-mo.tl o.ddTe88: annette. molinaro@yale . edu 
E-mo.tl o.ddTe88: tebohewm@lafayette.edu 
E-mo.tl o.ddTe88: margaret. baird@stonebow.otago. ae. nz 
E-mo.tl o.ddTe88: virion@ihug. co .nz 
E-mo.tl o.ddTe88: depillis@hme. edu 
